Preliminary BRAIN Plans

An NIH working group lays out nine research areas the new federal neuroscience initiative will fund.

Written byKate Yandell
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NIHIn April, President Barack Obama announced plans for a new federally funded neuroscience project, called the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. Earlier this week (September 16), a National Institutes of Health (NIH) working group released an interim report outlining nine broad areas the agency seeks to support.

All told, the BRAIN Initiative will fund $110 million worth of neuroscience research and training during fiscal year 2014. The NIH will dole out $40 million of that.

The research areas identified by the NIH working group are broad, though firmer priorities may be set in the group’s final report, due June 2014. “We haven’t made the toughest decisions yet,” working group co-chair Cori Bargmann, a neuroscientist at Rockefeller University, told Nature.

The group’s current priorities include performing a census of brain cell types, linking neuronal activity to behavior, improving tools for manipulating brain circuits, disseminating knowledge on neuroscience research tools, and more. The overarching goal is to understand how neural circuits interact to spur memories, emotions, and behaviors.

Gerald Rubin, executive director of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies